Adverum Biotechnologies Inc reports results for the quarter ended in March - Earnings Summary

Adverum Biotechnologies

14/05/2023 08:51

* Adverum Biotechnologies Inc  ADVM.OQ  reported a quarterly
adjusted loss of 29 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 32 cents per share.
    * Revenue was $3.60 million​; analysts expected zero. 
    * Adverum Biotechnologies Inc's reported EPS for the quarter
was a
loss of 29 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Adverum Biotechnologies Inc shares had risen by 17.1% this
quarter and gained 45.0% so far this year.
    * The company reported a quarterly loss of $29.06 million.
    * Wall Street's median 12-month price target for Adverum
Biotechnologies Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
14 at 07:51 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.32          -0.29          Beat
 Dec. 31 2022      -0.36          -0.33          Beat
 Sep. 30 2022      -0.34          -0.40          Missed
 Jun. 30 2022      -0.34          -0.44          Missed